This article includes discussion of suicide. If you or someone you know needs help, please call the National Suicide and Crisis Lifeline at 988.

On October 11, 2022, the student pharmacists and faculty at the University of Arkansas for Medical Services College of Pharmacy were invited to bring their favorite Hispanic dish to share and enjoy together.

Of the opportunities available to APhA–ASP members of International Pharmaceutical Students’ Federation (IPSF), few are as grand as the international conferences. There are 2 major conferences organized by IPSF: the World Congress and the regional symposia. This summer, members of the APhA–ASP International Standing Committee (ISC) had the privilege of attending the World Congress in Egypt and the Pan American Regional Symposium (PARS) in Chile.

In February 2022, Texas state legislature published statements equating gender-affirming therapy (GAT) to child abuse. This wasn’t an isolated incident, but in fact a single chapter of a series of functionally interchangeable manifestations of uninformed hostility springing forth across the country. The legislative movements in Texas, Florida, Arizona, Idaho, Mississippi, Tennessee, Alabama, and other states are motivated by intolerance and seek only to alienate those who are different from the ones enacting the policies. The policies target an already marginalized population, eliminating options for treatment and threatening them with worsening outcomes.

Pharmacists’ prescriptive authority is growing throughout the country, with Idaho being one of the most advanced states in this area.¹ In Idaho, pharmacists have prescriptive authority for conditions that do not require a new diagnosis or in emergency situations, minor/self-limiting conditions, or conditions diagnosed through a Clinical Laboratory Improvement Amendments–waived test.